Multicenter evaluation of whole-blood Epstein-Barr viral load standardization using the who international standard

Journal of Clinical Microbiology

Volumn 54, Issue 7, 2016, Pages 1746-1750

  Semenova, Touyana ^a,b   Lupo, Julien ^a,b   Alain, Sophie ^c   Perrin Confort, Gwladys ^b   Grossi, Laurence ^a   Dimier, Julie ^a   Epaulard, Olivier ^a,b   Morand, Patrice ^a,b   Germi, Raphaële ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HIGH RISK POPULATION; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; VIRUS IDENTIFICATION; VIRUS LOAD; WORLD HEALTH ORGANIZATION; BLOOD; CLINICAL TRIAL; EPSTEIN BARR VIRUS INFECTION; EVALUATION STUDY; FRANCE; ISOLATION AND PURIFICATION; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; PROCEDURES; REPRODUCIBILITY; STANDARD; STANDARDS; VIROLOGY;

BLOOD; EPSTEIN-BARR VIRUS INFECTIONS; FRANCE; HERPESVIRUS 4, HUMAN; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; VIRAL LOAD; WORLD HEALTH ORGANIZATION;

EID: 84976354778     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03336-15     Document Type: Article

References (17)

1. Luzuriaga K, Sullivan JL. 2010. Infectious mononucleosis. N Engl J Med 362:1993-2000. http://dx. doi. org/10. 1056/NEJMcp1001116.
2. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757-768. http://dx. doi. org/10. 1038/nrc1452.
3. Gärtner B, Preiksaitis JK. 2010. EBV viral load detection in clinical virology. J Clin Virol 48:82-90. http://dx. doi. org/10. 1016/j. jcv. 2010. 03. 016.
4. Kimura H, Ito Y, Suzuki R, Nishiyama Y. 2008. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol 18:305-319. http://dx. doi. org/10. 1002/rmv. 582.
5. Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF, Valsamakis A. 2016. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. [Epub ahead of print. ]
6. Green M, Michaels MG. 2013. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 13(Suppl 3): 41-54. http://dx. doi. org/10. 1111/ajt. 12004.
7. San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P. 2014. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clin Microbiol Infect 20(Suppl 7):109-118. http://dx. doi. org/10. 1111/1469-0691. 12534.
8. Yip TT, Ngan RK, Fong AH, Law SC. 2014. Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma. Oral Oncol 50:527-538. http://dx. doi. org/10. 1016/j.oraloncology. 2013. 12. 011.
9. Gulley ML, Tang W. 2010. Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev 23:350-366. http://dx. doi. org/10. 1128/CMR. 00006-09.
10. Germi R, Lupo J, Semenova T, Larrat S, Magnat N, Grossi L, Seigneurin JM, Morand P. 2012. Comparison of commercial extraction systems and PCR assays for the quantification of Epstein-Barr virusDNAload in whole blood. J Clin Microbiol 50:1384-1389. http://dx. doi. org/10. 1128/JCM.05593-11.
11. Hayden RT, Hokanson KM, Pounds SB, Bankowski MJ, Belzer SW, Carr J, Diorio D, Forman MS, Joshi Y, Hillyard D, Hodinka RL, Nikiforova MN, Romain CA, Stevenson J, Valsamakis A, Balfour HH, Jr, US EBV Working Group. 2008. Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol 46:157-163. http://dx. doi. org/10. 1128/JCM. 01252-07.
12. Preiksaitis JK, Pang XL, Fox JD, Fenton JM, Caliendo AM, Miller GG, American Society of Transplantation Infectious Diseases Community of Practice. 2009. Interlaboratory comparison of Epstein-Barr virus viral load assays. Am J Transplant 9:269-279. http://dx. doi. org/10. 1111/j. 1600-6143. 2008. 02514. x.
13. Abbate I, Zanchetta M, Gatti M, Gabrielli L, Zanussi S, Milia MG, Lazzarotto T, Tedeschi R, Ghisetti V, Clementi M, De Rossi A, Baldanti F, Capobianchi MR. 2011. Multicenter comparative study of Epstein-Barr virus DNA quantification for virological monitoring in transplanted patients. J Clin Virol 50:224-229. http://dx. doi. org/10. 1016/j. jcv. 2010. 12.002.
14. Pavŝic? J, Devonshire AS, Parkes H, Schimmel H, Foy CA, Karczmarczyk M, Gutiérrez-Aguirre I, Honeyborne I, Huggett JF, McHugh TD, Milavec M, Zeichhardt H, [caron]Zel J. 2015. Standardization of nucleic acid tests for clinical measurements of bacteria and viruses. J Clin Microbiol 53:2008-2014. http://dx. doi. org/10. 1128/JCM. 02136-14.
15. Fryer JF, Heath AB, Wilkinson DE, Minor PD, Collaborative Study Group. 2011. Collaborative study to evaluate the proposed 1st WHO international standard for Epstein-Barr virus (EBV) for nucleic acid amplification technology (NAT)-based assays. World Health Organization, Geneva, Switzerland. http://whqlibdoc. who. int/hq/2011/WHO-BS-2011.2172-eng. pdf.
16. Abeynayake J, Johnson R, Libiran P, Sahoo MK, Cao H, Bowen R, Chan KC, Le QT, Pinsky BA. 2014. Commutability of the Epstein-Barr virus WHOinternational standard across two quantitative PCR methods. J Clin Microbiol 52:3802-3804. http://dx. doi. org/10. 1128/JCM. 01676-14.
17. Rychert J, Danziger-Isakov L, Yen-Lieberman B, Storch G, Buller R, Sweet SC, Mehta AK, Cheeseman JA, Heeger P, Rosenberg ES, Fishman JA. 2014. Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards. Clin Transplant 28:1416-1423. http://dx. doi.org/10. 1111/ctr. 12473.